Switzerland· 69020001
Elymbus
A bimatoprost product containing bimatoprostum, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 19 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Bimatoprost is registered in 19 of 19 countries.
Countries holding a registration under ATC S01EE03 (bimatoprost), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 11 of them publish a price we can compare per daily dose
Bimatoprost · ATC S01EE03
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- bimatoprostum
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- S01EE03
- ATC class
- Bimatoprost
- Defined daily dose
- 0.1 ml, AT
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin768069020001530 Monodos 0.3 gCHF 33.7
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
89 interactions on record for bimatoprost.
Graded by severity as the source publishes them — 89 info. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Bimatoprost · interactions on record
89 records
Same medicine, other countries
Bimatoprost in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaELYMBUSLaboratoires Thea, Clermont-Ferrand
- BelgiumDuelym 0.1 mg/g - 1 mg/gLaboratoires Théa
- SpainELYMBUS 0,1 MG/G GEL OFTALMICO EN ENVASE UNIDOSISLaboratoires Thea
- FinlandElymbusLaboratoires Thea
- FranceELUMIBUS 0,1 mg/g, gel ophtalmique en récipient unidoseTHEA
- IrelandElymbus 0.1 mg/g eye gel in single-dose containerLaboratoires Thea
- IcelandElymbusLaboratoires Thea
- NetherlandsElymbus 0,1 mg/g ooggel in verpakking voor éénmalig gebruikLaboratoires Thea S.A.S.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Bima-Vision Sine, Bimato-Vision
- Belgium · Bimatoprost Eg, Bimatoprost Eg (Eurogenerics)
- Bulgaria · Бимаган, Биматопрост Абр
- Cyprus · Bimatoprost Pharmathen, Birmost
- Czechia · Bimatoprost Farmaprojects, Bimatoprost Olikla
- Germany · Amiriox, Bimato-Vision
- Denmark · Bimatoprost "hexal", Bimatoprost "stada"
- Estonia · Elymbus
- Spain · Amiriox, Bamixol
- Finland · Bimatoprost, Bimatoprost Sandoz
- France · Amiriox, Bimatoprost
- United Kingdom (Northern Ireland) · Amiriox, Bimatoprost Alissa Healthcare Research
- Greece · Birmost, Dacrysan
- Croatia · Elymbus
- Ireland · Elymbus, Eyreida
- Iceland · Bimatoprost, Elymbus
- Italy · Amiriox, Bialviz
- Liechtenstein · Lumigan
- Lithuania · Bimican, Bimifree
- Luxembourg · Bimatoprost Eg, Bimatoprost Eg (Eurogenerics) Nv
- Latvia · Bimican, Bimifre
- Netherlands · Bimagan, Bimato-Vision
- Norway · Bimaprez, Bimatoprost Hexal
- Poland · Bimican, Bimifree
- Portugal · Amiriox, Bimatoprost Stulln
- Romania · Amiriox, Bimagan
- Sweden · Bimaprez, Bimatoprost
- Slovenia · Elymbus
- Slovakia · Bimatoprost Olikla, Elymbus
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f158e5ad-e03c-4924-9047-d0597f549fc3 GET /v1/drugs/f158e5ad-e03c-4924-9047-d0597f549fc3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "bimatoprostum 0.1 mg",
"valid_from": "2024-10-01",
"limitations": null,
"galenic_form": "Augengel 0.1 mg/g",
"therapeutic_area": null,
"sl_inclusion_date": "2024-10-01",
"self_retention_pct": 10
}See everything about bimatoprost.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.